Continuous glucose monitoring technology with and without insulin pump therapy is an emerging attractive approach to help insulin-treated people with DKD optimise their glycaemic control
[1] [3] For Zepbound (obesity indication), similar effects occur but with higher rates of constipation (17-26%) and additional common reactions including dyspepsia, gastroesophageal reflux disease, and hair loss (alopecia)
View Source Physiology & behavior The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism 2024 DOI: 10.1016/j.physbeh.2024.114644 PMID: 39043357 Lu Z, Ngan MP, Liu JYH, et al
Muscle tissue is metabolically expensive
Regular testing helps catch problems early and reduces the chance of serious complications
The goal is to build a routine you can sustain in the long term, not to follow a programme that feels overwhelming that you give up after a few weeks